|
|
| 16.76 Data as of Mar 12 |  +0.91 / +5.74%Today’s Change | 9.52 Today|||52-Week Range 19.00 | -2.33% Year-to-Date |
| Wednesday's Top Upgrades (and Downgrades) Mar 12 / MotleyFool.com | Cyberonics Upped to Buy - Analyst Blog Mar 03 / Zacks.com |
| AngioDynamics Gets 3rd FDA Approval for BioFlo - Analyst Blog Mar 10 / Zacks.com | BioScrip Down on Q4 Loss, Poor Outlook - Analyst Blog Feb 28 / Zacks.com |
| Coverage on Covance Initiated - Analyst Blog Mar 06 / Zacks.com | Fresenius Medical Care Beats on Q4 Earnings - Analyst Blog Feb 27 / Zacks.com |
| Previous close | 15.85 |
| Today’s open | 16.12 |
| Day’s range | 16.07 - 16.90 |
| Volume | 343,500 |
| Average volume (3 months) | 169,276 |
| Market cap | $559.7M |
| Dividend yield | -- |
| Earnings growth (last year) | +90.00% |
| Earnings growth (this year) | -5.71% |
| Earnings growth (next 5 years) | +15.00% |
| Revenue growth (last year) | +54.21% |
| P/E ratio | NM |
| Price/Sales | 1.11 |
| Price/Book | 1.05 |
| Today’s change | Today’s % change | |
|---|---|---|
| ATRSAntares Pharma Inc | -0.01 | -0.23% |
| RMTIRockwell Medical Inc | -0.16 | -1.21% |
| ANIKAnika Therapeutics I... | +0.04 | +0.10% |
| TNDMTandem Diabetes Care... | -0.71 | -2.72% |
| Next reporting date | April 2, 2014 |
| EPS forecast (this quarter) | $0.09 |
| Annual revenue (last year) | $342.0M |
| Annual profit (last year) | -$612.0K |
| Net profit margin | -0.18% |
Sector Health Technology |
Industry Medical Specialties |
President, Chief Executive Officer & Director Joseph M. DeVivo |
Chief Technology & Operations Officer, SVP George W. Bourne |
Corporate headquarters Latham, New York |
.
